 |
 |
|
Your safety is the number one priority in a
clinical trial. The safety and rights of human subjects are protected in several ways.
First, all federally-funded and federally-regulated clinical trials (including those conducted at CCT)
must be approved by an Institutional Review Board (IRB). An IRB is a group of people who review and
approve or disapprove research studies involving people by following the Food and Drug Administration
(FDA) rules. The group is also required by the FDA to do periodic review of ongoing research studies.
The primary purpose of such review is to ensure the protection of the rights and welfare of human subjects.
Second, any subject that participates in a clinical trial must sign an "informed consent" form,
which discusses the nature of the study, potential benefits and risks, and the right of the
volunteer to leave the study at any time.
Third, CCT, utilizes Good Clinical Practice principles, along with Quality Assurance teams to
ensure and maintain each individual's rights and personal safety while a study participant.
We take the time to obtain a complete and accurate medical history and diagnosis. And, we
perform a detailed review of all aspects of a clinical trial protocol with each potential
study participant to ensure complete understanding, and to make sure it agrees with his or
her expectations and goals.
We believe that quality research is the result of using state-of-the-art facilities in
combination with well-trained clinical professional, working with well-informed study participants.
|
|
|
|
